Intertrigo Treatment
The recommended treatment for intertrigo is keeping the affected area clean and dry combined with topical antifungal agents (clotrimazole, miconazole, or nystatin) as first-line therapy for candidal intertrigo, with topical antibacterials (mupirocin or clindamycin) when bacterial infection is suspected. 1, 2
Primary Management: The Foundation
- Moisture control is the single most critical intervention for successful treatment and must be implemented before or alongside any pharmacological therapy 1
- Thoroughly dry intertriginous areas after bathing using separate clean towels for the groin versus other body parts 2
- Use moisture-wicking textiles within skin folds to reduce skin-on-skin friction, wick away moisture, and prevent secondary infection 2, 3
- Patients should wear light, nonconstricting, absorbent clothing and avoid wool and synthetic fibers 4
- For toe web intertrigo specifically, wearing open-toed shoes provides benefit 4
Pharmacological Treatment Algorithm
For Candidal Intertrigo (Most Common)
First-line topical antifungals: 1, 5
- Azoles: clotrimazole cream or miconazole cream
- Polyenes: nystatin cream or powder
- Apply to affected areas after ensuring they are clean and dry
For extensive or resistant candidal cases: 1
- Oral fluconazole 100-200 mg daily for 7-14 days, OR
- Oral itraconazole solution 200 mg daily
For Bacterial Intertrigo
When bacterial infection is suspected (look for purulent drainage, crusting, or honey-colored exudate): 1
- Topical mupirocin ointment, OR
- Topical clindamycin lotion
For suspected MRSA involvement: 1
- Oral doxycycline, OR
- Oral trimethoprim-sulfamethoxazole
For bullous or nonbullous impetigo: 1
- Topical mupirocin twice daily for 5 days, OR
- Topical retapamulin twice daily for 5 days
Special Clinical Scenarios
High-Risk Patients Requiring Aggressive Management
Patients with obesity, diabetes mellitus, or immunocompromised status need more intensive treatment as these conditions perpetuate intertrigo 1, 6
- Address underlying predisposing factors: encourage weight loss, optimize glycemic control, manage immunosuppression 6
- Investigate and treat intestinal colonization or periorificial candidal infections in recurrent cases 6
Recurrent Intertrigo
- Implement maintenance therapy with intermittent application of topical antifungals 1
- Investigate potential sources of reinfection (intestinal colonization, periorificial sites) 6
- Consider novel systemic agents with higher potency if predisposing immunosuppressive conditions exist 6
Intertrigo with Inverse Psoriasis
This requires a different approach due to the inflammatory component: 1
- Use low-potency topical corticosteroids, OR
- Calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus) as steroid-sparing agents
- Avoid high-potency corticosteroids in skin folds due to increased risk of atrophy and systemic absorption 1
- Tacrolimus 0.1% ointment achieves clear or almost clear skin in 65% of patients after 8 weeks 1
- Calcineurin inhibitors are particularly useful for prolonged use (≥4 weeks) in thin-skinned intertriginous areas 1
Common Pitfalls to Avoid
- Do not use absorptive powders like cornstarch in candidal intertrigo, as these can serve as a nutrient source for Candida; barrier creams are preferred 4
- Avoid high-potency topical corticosteroids in skin folds even when inflammation is present, as the occlusive environment increases systemic absorption and atrophy risk 1
- Do not treat empirically without considering the infectious etiology: candidal intertrigo requires antifungals, bacterial requires antibacterials, and mixed infections require combination therapy 1, 4
- Patients should shower after physical exercise and thoroughly dry intertriginous areas, as moisture accumulation from sweat perpetuates the condition 4
Treatment Escalation Pathway
- Initial approach: Basic hygiene measures + topical antifungal (if candidal suspected) or antibacterial (if bacterial suspected) 1
- If persistent after 2 weeks: Consider oral antifungal therapy (fluconazole or itraconazole) 1
- If recurrent: Implement maintenance therapy and investigate reinfection sources 1, 6
- If treatment-resistant: Perform laboratory confirmation (KOH prep, culture) to establish differential diagnosis and guide targeted therapy 6